RCM Eos PIPE HOLDINGS Acquires 9.99% Stake in Pulmatrix, Inc. via Preferred Stock Investment

2026-04-22SEC Filing SCHEDULE 13D (0001104659-26-046851)

On April 16, 2026, RCM Eos PIPE HOLDINGS, LLC, along with Rapha Capital Management, LLC and Kevin Slawin, acquired 1,000 shares of Series B Convertible Preferred Stock of Pulmatrix, Inc. (PULM) for $1,000,000. This investment represents a 9.99% beneficial ownership stake in the company's common stock upon conversion, which is currently limited by a beneficial ownership blocker. The acquisition was made to provide interim financing for Pulmatrix ahead of a planned merger with Eos SENOLYTIX, Inc. Under the terms of the Merger Agreement, Eos stockholders are expected to own approximately 94% of the combined entity post-closing. In connection with the purchase, RCM Eos entered into a Voting Agreement to support the merger and related transactions. Kevin Slawin, who manages Rapha and RCM Eos, is also the CEO and a director of Eos SENOLYTIX. Following the merger, it is anticipated that Eos will replace the Pulmatrix board of directors and the company will pivot to Eos's business operations.

Ticker mentioned:PULMInstitution mentioned:RCM Eos PIPE HOLDINGS, LLC
Related industry:Biotechnology